Published in Menopause on July 09, 2009
Negative affect and vasomotor symptoms in the Study of Women's Health Across the Nation Daily Hormone Study. Menopause (2011) 2.19
Symptom clusters during the late reproductive stage through the early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause (2012) 1.59
Endocrine biomarkers and symptom clusters during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause (2014) 1.45
Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause (2014) 1.44
Efficacy of yoga for vasomotor symptoms: a randomized controlled trial. Menopause (2014) 1.44
Evaluation and management of sleep disturbance during the menopause transition. Semin Reprod Med (2010) 1.39
Menopause-associated symptoms and cognitive performance: results from the study of women's health across the nation. Am J Epidemiol (2010) 1.22
Perimenopause as a neurological transition state. Nat Rev Endocrinol (2015) 1.14
Perimenopause and cognition. Obstet Gynecol Clin North Am (2011) 0.94
Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation. Obstet Gynecol Clin North Am (2011) 0.91
Lifetime history of depression and anxiety disorders as a predictor of quality of life in midlife women in the absence of current illness episodes. Arch Gen Psychiatry (2012) 0.88
Evaluation of the potential antidepressant effects of soybean isoflavones. Menopause (2016) 0.85
Factors that may influence the experience of hot flushes by healthy middle-aged women. J Womens Health (Larchmt) (2010) 0.83
Metabolic activity in the insular cortex and hypothalamus predicts hot flashes: an FDG-PET study. J Clin Endocrinol Metab (2012) 0.79
Effects of pharmacologically induced hypogonadism on mood and behavior in healthy young women. Am J Psychiatry (2013) 0.78
Menopausal Symptoms and Their Management. Endocrinol Metab Clin North Am (2015) 0.77
Epidemiology of the symptoms of menopause - an intercontinental review. Prz Menopauzalny (2014) 0.76
The role of cytokines and hot flashes in perimenopausal depression. Ann Gen Psychiatry (2012) 0.76
Independent Contributions of Nocturnal Hot Flashes and Sleep Disturbance to Depression in Estrogen-Deprived Women. J Clin Endocrinol Metab (2016) 0.76
Symptom severity of bipolar disorder during the menopausal transition. Int J Bipolar Disord (2015) 0.75
Optimal management of perimenopausal depression. Int J Womens Health (2010) 0.75
Perimenopause: From Research to Practice. J Womens Health (Larchmt) (2015) 0.75
Measuring hot flash phenomenonology using ambulatory prospective digital diaries. Menopause (2016) 0.75
Perimenopausal syndrome and mood disorders in perimenopause: prevalence, severity, relationships, and risk factors. Medicine (Baltimore) (2016) 0.75
A global measure of perceived stress. J Health Soc Behav (1983) 56.90
Simulation study of confounder-selection strategies. Am J Epidemiol (1993) 12.76
Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health (2006) 4.51
Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry (2006) 3.70
Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause (2003) 3.57
Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry (2006) 3.55
Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry (2004) 3.13
Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). J Affect Disord (2007) 2.74
The role of anxiety and hormonal changes in menopausal hot flashes. Menopause (2005) 2.70
Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol (2007) 2.65
Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause (2005) 2.50
Measuring the impact of menopausal symptoms on quality of life. BMJ (1993) 2.42
Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause (2008) 2.22
The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab (2005) 2.15
Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med (2005) 1.86
A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry (2004) 1.47
Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril (2005) 1.47
Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation. Am J Epidemiol (2007) 1.46
Predictors of first lifetime episodes of major depression in midlife women. Psychol Med (2008) 1.13
Risk factors for hot flashes in midlife women. J Womens Health (Larchmt) (2003) 1.12
Psychometric properties of a menopausal symptom list. Menopause (2003) 1.05
Influence of menopause on mood: a systematic review of cohort studies. Climacteric (2007) 0.95
A cross-sectional evaluation of perimenopausal depression. J Clin Psychiatry (2008) 0.95
Neurobehavioral impact of menopause on mood. Expert Rev Neurother (2007) 0.82
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood (2003) 3.86
Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry (2006) 3.55
Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry (2004) 3.13
The role of anxiety and hormonal changes in menopausal hot flashes. Menopause (2005) 2.70
Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA (2011) 2.70
Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol (2007) 2.65
Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause (2005) 2.50
Maternal complications with vaginal birth after cesarean delivery: a multicenter study. Am J Obstet Gynecol (2005) 2.14
Obesity and reproductive hormone levels in the transition to menopause. Menopause (2010) 2.10
Acupuncture--help, harm, or placebo? Fertil Steril (2013) 2.02
Janus kinase 2: a critical target in chronic myelogenous leukemia. Cancer Res (2006) 1.99
Body size affects measures of ovarian reserve in late reproductive age women. Menopause (2008) 1.93
Adverse neonatal outcomes: examining the risks between preterm, late preterm, and term infants. Am J Obstet Gynecol (2008) 1.92
Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia. Cancer Res (2004) 1.90
Symptomatic patients with an early viable intrauterine pregnancy: HCG curves redefined. Obstet Gynecol (2004) 1.88
Molecular engineering of DNA: molecular beacons. Angew Chem Int Ed Engl (2009) 1.84
A disintegrin and metalloprotease protein-12 as a novel marker for the diagnosis of ectopic pregnancy. Fertil Steril (2011) 1.76
Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril (2006) 1.75
Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause (2014) 1.75
Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab (2012) 1.67
Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med (2013) 1.61
Brief communication: physical abuse of boys and possible associations with poor adult outcomes. Ann Intern Med (2005) 1.55
Predictors of decreased libido in women during the late reproductive years. Menopause (2004) 1.54
Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene (2002) 1.54
Comparing postcesarean infectious complication rates using two different skin preparations. Obstet Gynecol (2011) 1.50
Keeping donor hearts in completely beating status with normothermic blood perfusion for transplants. Ann Thorac Surg (2013) 1.48
Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res (2009) 1.43
Hormones and sexuality during transition to menopause. Obstet Gynecol (2007) 1.42
Urinary incontinence and psychological distress in community-dwelling older adults. J Am Geriatr Soc (2002) 1.38
Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer (2010) 1.38
Interim analysis in clinical trials. Fertil Steril (2012) 1.37
Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet (2004) 1.35
Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Arch Intern Med (2004) 1.32
Duration of menopausal hot flushes and associated risk factors. Obstet Gynecol (2011) 1.31
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause (2014) 1.31
Association between socio-psycho-behavioral factors and male semen quality: systematic review and meta-analyses. Fertil Steril (2010) 1.29
Impact of cancer therapies on ovarian reserve. Fertil Steril (2011) 1.28
A functional SNP in the promoter of the SERPINH1 gene increases risk of preterm premature rupture of membranes in African Americans. Proc Natl Acad Sci U S A (2006) 1.27
Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS). Am J Obstet Gynecol (2010) 1.26
Predictors of prognosis in patients with olfactory disturbance. Ann Neurol (2008) 1.25
Temporal and spatial changes in transcription factor binding and histone modifications at the steroidogenic acute regulatory protein (stAR) locus associated with stAR transcription. Mol Endocrinol (2004) 1.22
Decline of serum human chorionic gonadotropin and spontaneous complete abortion: defining the normal curve. Obstet Gynecol (2004) 1.21
The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network. J Drug Target (2009) 1.20
Community health needs assessment with precede-proceed model: a mixed methods study. BMC Health Serv Res (2009) 1.20
Factors impacting the departure rates of female and male junior medical school faculty: evidence from a longitudinal analysis. J Womens Health (Larchmt) (2012) 1.19
Is vaginal birth after cesarean (VBAC) or elective repeat cesarean safer in women with a prior vaginal delivery? Am J Obstet Gynecol (2006) 1.19
Poor sleep in relation to natural menopause: a population-based 14-year follow-up of midlife women. Menopause (2015) 1.17
Application of redefined human chorionic gonadotropin curves for the diagnosis of women at risk for ectopic pregnancy. Fertil Steril (2006) 1.17
Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril (2007) 1.16
A deletion mutation in the betaA1/A3 crystallin gene ( CRYBA1/A3) is associated with autosomal dominant congenital nuclear cataract in a Chinese family. Hum Genet (2003) 1.16
Risk factors for ectopic pregnancy in women with symptomatic first-trimester pregnancies. Fertil Steril (2006) 1.16
Predictors of sleep quality in women in the menopausal transition. Sleep (2008) 1.16
Periodontal disease and adverse pregnancy outcomes: is there an association? Am J Obstet Gynecol (2009) 1.14
Human chorionic gonadotropin profile for women with ectopic pregnancy. Obstet Gynecol (2006) 1.14
Molecular assembly of superquenchers in signaling molecular interactions. J Am Chem Soc (2005) 1.14
Performance of human chorionic gonadotropin curves in women at risk for ectopic pregnancy: exceptions to the rules. Fertil Steril (2012) 1.14
Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet Gynecol (2008) 1.14
Use of "2-dose" regimen of methotrexate to treat ectopic pregnancy. Fertil Steril (2006) 1.14
Men's pathways to risky sexual behavior: role of co-occurring childhood sexual abuse, posttraumatic stress disorder, and depression histories. J Urban Health (2005) 1.11
Factors that influence entry into stages of the menopausal transition. Menopause (2009) 1.11
Semen quality of 1346 healthy men, results from the Chongqing area of southwest China. Hum Reprod (2008) 1.10
Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained infertility? A systematic review and meta-analysis. Fertil Steril (2013) 1.10
Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients. World J Gastroenterol (2009) 1.09
The relationship between obesity and race on inhibin B during the menopause transition. Menopause (2005) 1.09
Menopause effects on verbal memory: findings from a longitudinal community cohort. J Clin Endocrinol Metab (2013) 1.07
The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. J Leukoc Biol (2011) 1.07
A single nucleotide polymorphism in the promoter of the LOXL1 gene and its relationship to pelvic organ prolapse and preterm premature rupture of membranes. Reprod Sci (2009) 1.06
Evidence of a gene-environment interaction that predisposes to spontaneous preterm birth: a role for asymptomatic bacterial vaginosis and DNA variants in genes that control the inflammatory response. Am J Obstet Gynecol (2010) 1.05
The null hypothesis: closing the gap between good intentions and good studies. Fertil Steril (2011) 1.05
Psychometric properties of a menopausal symptom list. Menopause (2003) 1.05
Synthesis and investigation of deoxyribonucleic acid/locked nucleic acid chimeric molecular beacons. Nucleic Acids Res (2007) 1.05
Clinical factors affecting the accuracy of ultrasonography in symptomatic first-trimester pregnancy. Obstet Gynecol (2011) 1.05
Identification of Multivariate Responders/Non-Responders Using Bayesian Growth Curve Latent Class Models. J R Stat Soc Ser C Appl Stat (2009) 1.04
Geographic patterns of cancer mortality clusters in Texas, 1990 to 1997. Tex Med (2003) 1.04
Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors. Fertil Steril (2009) 1.04
Patterns of expression of sperm flagellar genes: early expression of genes encoding axonemal proteins during the spermatogenic cycle and shared features of promoters of genes encoding central apparatus proteins. Mol Hum Reprod (2005) 1.04
Tracing the stemness of porcine skin-derived progenitors (pSKP) back to specific marker gene expression. Cloning Stem Cells (2009) 1.04
Elucidating the early signal transduction pathways leading to fetal brain injury in preterm birth. Pediatr Res (2005) 1.03
Genetic and epigenetic mechanisms combine to control MMP1 expression and its association with preterm premature rupture of membranes. Hum Mol Genet (2008) 1.01
Development of a multiple marker test for ectopic pregnancy. Obstet Gynecol (2011) 1.01
Development of a clinical prediction rule for iron deficiency anemia in pregnancy. Am J Obstet Gynecol (2005) 1.01
A new NAD(H)-dependent meso-2,3-butanediol dehydrogenase from an industrially potential strain Serratia marcescens H30. Appl Microbiol Biotechnol (2013) 1.00
Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors. Breast Cancer Res Treat (2010) 0.99
Role of estrogen in hepatocellular carcinoma: is inflammation the key? J Transl Med (2014) 0.99
Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy. Fertil Steril (2012) 0.99
Prediction of location of a symptomatic early gestation based solely on clinical presentation. Obstet Gynecol (2008) 0.99